Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - yang
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel Murine T-Cell Receptors for Treating Metastatic Thyroid Cancer
Abstract: The occurrence of thyroid cancer has been increasing in the United States. For some patients, with particularly advanced and metastatic cancer, current treatments such as thyroidectomy and adjuvant radioactive iodine therapy can lead to poor outcomes. Hence, there is a need for new thyroid cancer treatments. Researchers at the NCI have developed...
Published: 4/8/2024
|
Inventor(s):
Kenichi Hanada
,
Qiong Wang
,
James
Yang
,
Zhiya Yu
Keywords(s):
act
,
adoptive cell therapy
,
Human Thyroglobulin
,
Immunotherapy
,
METASTATIC
,
T-cell Receptors
,
TCR
,
TCRs
,
Tg
,
THYROID CANCER
,
Yang
Category(s):
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Oncology
,
Collaboration Sought > Collaboration
T Cell Receptors Targeting BRAF V600E Mutation for Cancer Immunotherapy
Abstract: BRAF is an oncogene that encodinges a serine-threonine kinase (B-Raf kinase) important in regulating cell growth and differentiation. Spontaneous mutations in the BRAF gene allow cells to continuously divide, leading to the development of cancer. A substitution of glutamic acid for valine at amino acid number 600 (designated V600E) accounts...
Published: 12/6/2024
|
Inventor(s):
Zhiya Yu
,
Catherine Ade
,
Matthew Sporn
,
James
Yang
,
Kenichi Hanada
Keywords(s):
BRAF
,
B-Raf kinase
,
B-Raf Proto-Oncogene
,
HLA-A*0301 restriction
,
Immunotherapy
,
Rosenberg
,
serine-threonine kinase
,
T Cell Receptor
,
T cell therapy
,
TCR
,
V600E mutation
,
Yang
,
Yu
Category(s):
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
Collaboration Sought > Licensing